I would post my pick but HOSS doesn't like it LMAO. Ask him

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

QHSLab Celebrates a New Milestone in Drug Delivery Technology QHSLab Inc. (OTCQB: USAQ), known for its pioneering approaches in digital healthcare solutions, has been granted a prestigious opportunity by the National Science Foundation (NSF). The invitation to submit a full application for their groundbreaking AIR-GUIDDE (Airway Instantaneous Regional Guided Interface for...

Guns N' Roses' Iconic Track Chosen for Gundam Film Theme Today, Bandai Namco Filmworks has revealed an exciting collaboration: the celebrated rock ballad "Sweet Child O' Mine" by Guns N' Roses will grace the ending credits of the much-anticipated film MOBILE SUIT GUNDAM HATHAWAY The Sorcery of Nymph Circe. As fans eagerly await the release, the emotional depth of the song...

Arko's Strategic Shift in the Convenience Store Market Arko, based in Richmond, Virginia, is in the spotlight as it explores the possibility of selling off its convenience store operations. This deal could be worth around $2 billion and signifies a notable pivot in the company's approach amidst challenges in the retail industry. As discussions unfold, it appears Arko is...

Galaxy Therapeutics Strengthens Leadership with New CMO In a notable step forward, Galaxy Therapeutics has announced the appointment of Dr. Michael Alexander as Chief Medical Officer. This move aligns perfectly with the company’s objectives of enhancing its clinical and scientific teams as they work towards the development and eventual commercialization of their...

World Heritage initiatives roared through the scene, pushing for a blend of culture and dialogue that few could ignore. Nations weren’t just hanging on; they were diving headfirst into programs like the Global Development Initiative (GDI) and the Global Security Initiative (GSI). These aren't just talk shops; they're part of a broader movement to enhance human...